ÂÜÀòÂÒÂ×

SHAORONG (Ron) CHONG is an accomplished scientist with extensive experience in CRISPR technology and protein engineering. Currently serving as Vice President of CRISPR Technology Development at Life Edit Therapeutics since March 2022, Ron previously held significant roles at Arbor Biotechnologies from May 2017 to February 2022, including Discovery Strategy Fellow and Director of Protein Engineering, where efforts focused on high throughput CRISPR discovery. Prior to that, Ron spent over two decades at New England Biolabs as a Senior Principal Scientist, working on protein discovery and engineering platforms. Ron holds a PhD in Natural Products Chemistry and Pharmacognosy from the University of Michigan and a Bachelor's degree in Plant Physiology and Biochemistry from Peking University.